Synthyra
Research

Case Study

7 min read

From Generated Sequence to Measured Binding

A diffusion protein language model generated binder candidates for EGFR and PD-L1, and 40 of them were expressed and assayed. This is what the measurements showed, including the failures, and how they relate to what the model actually predicted.

Logan Hallee

July 31, 2025

Measured dissociation constants for every EGFR and PD-L1 design that produced a fitted value
Every design that yielded a fitted dissociation constant, both replicates shown. One EGFR design beats the best known binder. The whole PD-L1 series falls well short of its reference.

Protein sequences are almost free to generate. A model can emit a hundred thousand candidates for a target overnight, and every one of them will look plausible in the only sense software can check, which is that some other piece of software scores it well.

Experimental capacity is not free. The interesting transition is therefore never from one computational score to another. It is from a proposed sequence to a physical molecule that either expresses in a cell or does not, and either sticks to its target or does not.

Forty DSM designs made that crossing. This is what happened to them.

Two sources, kept separate

Representation and generation results in the DSM manuscript are all computational. The binding affinity numbers are predictions from a separate model, and the authors state that they "relied on in-silico proxies for secondary structure, function, and binding affinity." The measured binding data described below sits in the project repository and does not appear in the manuscript. Where this article says "measured," it means the repository data. Where it says "predicted," it means the paper.

What the model is

Most protein language models are trained by masking about 15 percent of a sequence and asking the model to fill in the gaps. That produces excellent representations and a weak generator, because a model that has only ever seen lightly corrupted inputs has no idea what to do with a mostly blank one.

DSM changes the corruption schedule. Instead of a fixed 15 percent, the mask rate is drawn uniformly from zero to one on every batch, and the loss is reweighted by that rate so low-mask examples are penalized harder. The model therefore trains across the entire corruption range, from nearly-complete sequences down to nearly-empty ones. Generation is then the same operation run in reverse: start from all mask tokens and fill in.

Training details

DSM extends pretrained ESM2 checkpoints with the LLaDA masked-diffusion objective, plus a modified language modeling head with a soft logit cap and tied output projection. The 650 million parameter model was trained on OMG-Prot50, over 207 million sequences clustered at 50 percent identity, at a global batch size of 128 and a maximum length of 2,048. That run took 12 days on four A100 GPUs. A LoRA-adapted variant, DSM-ppi, conditions generation on a target sequence by giving the model the target intact and the binder masked.

The payoff of the variable mask rate shows up at high corruption. Even at 90 percent masking, DSM reconstructs sequences with an alignment score around 0.27, which is more than four standard deviations above what randomly paired natural proteins score. It also holds a 2.4 to 37.8 percent F1 advantage over DPLM depending on mask rate. Below 15 percent masking, ordinary ESM2 models are better, a fair trade since that is the regime they were built for.

Sequence reconstruction accuracy on the interaction test set for ESM2 and DSM model variants
Figure 1. Rebuilding a masked partner sequence at 15 percent masking on a leakage-controlled test set of 1,320 interaction pairs. The target-conditioned DSM-ppi variants receive both sequences; every other model sees only the masked one. Numbers from the supplementary table.

The conditioning works, though modestly. Giving the model the target sequence lifts reconstruction accuracy from 31.4 to 33.0 percent at the 150 million parameter scale, and the control that receives the same extra training without the target lands in between at 31.9 percent. So roughly half the gain is target information and half is simply more training.

The designs, and where they came from

For binder generation the evaluation uses BenchBB, a set of seven targets each paired with a literature-derived best-known binder: EGFR, IL-7Rα, MBP, PD-L1, BBF-14, BHRF1, and Cas9. For each target, 100,000 candidates were generated by masking a template binder at a uniformly random rate and letting DSM fill it back in, for 1.4 million sequences in total.

Share of designs scoring above the best known binder, per target, for conditional and unconditional generation
Figure 2. Fraction of 100,000 designs per target whose predicted binding affinity exceeds the best known binder. These are predictions from a separate affinity model, not measurements. The unconditional method, which never sees the target sequence, wins on six of seven targets.

That observation deserves more scrutiny. The target-conditioned DSM-ppi model was the point of the fine-tuning, and by this metric the unconditional model beats it almost everywhere. There are benign explanations. The template already encodes a great deal about the target, and the predicted-affinity scorer may simply prefer sequences closer to the template distribution. But the comparison goes undiscussed, and on the reported numbers the case for conditioning is weaker than the framing suggests.

The y-axis matters here. "Success rate" here means a second model predicted a higher affinity. That is a screening signal, not a result.

Into the lab

Twenty EGFR designs and twenty PD-L1 designs were expressed and assayed, two replicates each, across a five-point concentration series. The first thing that happens to a designed protein is not binding. It is expression, and expression is where designs die.

Expression level and binding signal for twenty EGFR and twenty PD-L1 designs
Figure 3. Outcome for every design in the campaign, taking the better of two replicates. The EGFR series lost 8 of 20 candidates before any binding question could be asked. The PD-L1 series expressed at high level across the board.

The two campaigns failed and succeeded in opposite ways. Every PD-L1 design expressed at high level; 8 of 20 EGFR designs produced nothing at all. Of the designs that did express, 11 EGFR and 15 PD-L1 candidates yielded a fitted dissociation constant.

Measured dissociation constants per design for both targets, log scale, against the reference binder
Figure 4. Every fitted dissociation constant, both replicates, on a log scale. The dashed line is the best known binder for each target, converted from the pKd values recorded in the benchmark table. Designs beating that line are highlighted.

Measured outcomes

0.861nM

Best EGFR design

dsm_egfr_10, mean of 0.628 and 1.095 nM; reference binder is 1.20 nM

11of 20

EGFR designs with a fitted constant

8 never expressed, 1 expressed without binding

8.06nM

Best PD-L1 design

dsm_pdl1_7; reference binder is 0.04 nM, roughly 190-fold tighter

The EGFR campaign produced a genuine result. One design, dsm_egfr_10, bound recombinant EGFR at a mean fitted dissociation constant of 0.861 nM across two replicates, which is tighter than the 1.20 nM reference binder taken from the literature. Five more designs landed within a few-fold of it. A generated sequence survived expression and outperformed the incumbent on the target it was designed against.

The PD-L1 campaign did not. Everything expressed, most designs bound something, and the best of them was still roughly 190-fold weaker than the reference binder. Reading only the EGFR half of this campaign would give a badly distorted picture of what the system currently does.

What this does not show

These are two targets, forty designs, and two replicates apiece. No structure was solved, so the geometry of any of these interactions is unknown. Binding to a purified recombinant target under assay conditions is not the same as engaging that target in a cell, in tissue, or in an organism. And a single strong hit out of forty attempts, on one of two targets, is a starting point rather than a demonstrated capability.

Predicted against measured

The most useful thing about having both halves is that they can be compared, and the comparison is not flattering to the predictions.

By the model's own predicted-affinity screen, EGFR was the hardest of the seven targets: only 0.59 percent of conditional designs and 3.55 percent of unconditional ones scored above the reference binder, the lowest rates in the whole benchmark. PD-L1 looked considerably more promising at 12.64 and 12.75 percent.

The measurements inverted that. EGFR produced the campaign's one clear win. PD-L1, the more promising target on paper, produced nothing near its reference.

Predicted affinity is a filter that makes a 100,000-candidate pool small enough to test. It is not a ranking you should trust to be correct in its details. The DSM authors note in their limitations that integrating wet-lab feedback is "a natural next step." These forty measurements are the first increment of exactly that feedback, and their main value is as training signal about where the predictions go wrong.

Terms used here

Dissociation constant (K_D). The concentration at which half the target is bound. Smaller is tighter. Nanomolar is strong; picomolar is very strong.
pKd. The negative base-10 logarithm of the dissociation constant in molar units. A pKd of 9 is 1 nM. Used because affinities span many orders of magnitude.
Expression. Getting a cell to actually manufacture the designed protein in soluble, usable form. A design that cannot be made cannot be tested.
Masked diffusion. Training a model to reconstruct sequences corrupted at every level from lightly masked to fully masked, which lets the same model both represent and generate.

What this establishes

Narrowly: a masked-diffusion protein language model produced a candidate that expressed, bound its target, and measured tighter than the best binder reported for that target in the literature. That crossing from software to a physical molecule with a number attached to it is the part that counts, and most generated sequences never make it.

Just as narrowly: the same system produced eight EGFR designs that could not be manufactured, and an entire PD-L1 series that fell far short. The predicted-affinity screen that was supposed to tell the two campaigns apart got their relative difficulty backwards.

Both of those are the result. A design system is characterized by its hit rate and its failure modes together, and forty measurements is enough to see the shape of both while being nowhere near enough to fix either.

Source

Diffusion Sequence Models for Enhanced Protein Representation and Generation

Logan Hallee, Nikolaos Rafailidis, David B. Bichara, Jason P. Gleghorn

arXiv preprint, June 2025. The binding measurements described here are not part of the preprint.

Read the paper Code

Continue reading

Related research

News · August 25, 2026

Stephen Wolfram Joins Synthyra as Advisor

Stephen Wolfram, PhD, creator of Mathematica, Wolfram|Alpha, and the Wolfram Language, joins Synthyra as an advisor on computational systems and scientific software.

News · August 10, 2026

Diane Heiser Joins Synthyra as Advisor

Biotech executive and scientific founder Diane Heiser, PhD, joins Synthyra as an advisor on company building, partnerships, and translation.

Synthyra

Optimize the outcome, not the interface.

Biological design programs selected on the predicted state of the system, not the quality of one contact.

Platform

DiscoverDemosModelsAPI

Company

NewsOur VisionTeamContactOpen sourceSign in

© 2026 Synthyra. All rights reserved.

TermsPrivacy